Research & News

Mode of Delivery and Infant Respiratory Morbidity

Oct 05, 2010

A study examining the risk of infant respiratory morbidity associated with cesarean delivery before labor and rupture of membranes in HIV-infected women found low rates of respiratory distress syndrome. The authors conclude there is minimal neonatal respiratory morbidity... Read More

Postpartum HIV Care for Women in Mississippi

Oct 04, 2010

A study of HIV-infected pregnant women in Mississippi found only 37% had two or more visits with an HIV specialist in the year following delivery. Women who presented before the third trimester of pregnancy had better follow-up rates than those with late trimester... Read More

Missed Opportunities in Perinatal HIV Prevention

Sep 30, 2010

The Enhanced Perinatal Surveillance (EPS) data collected in 10 states and 5 cities from 2005-2008 showed a number of missed opportunities for prevention of transmission of HIV from mom to baby. Overall, 60% of women did not receive all the recommended interventions to... Read More

The Intersection of HIV and Maternal Mortality

Sep 14, 2010

Worldwide, the top two causes of death in women of reproductive age are HIV/AIDS and complications related to pregnancy. Respectively, these account for 19 and 15 percent of all deaths in women aged 15-44 years. Though the majority of women survive for many years after... Read More

Risk Factors for Detectable HIV-1 RNA at Delivery

Sep 14, 2010

In the United States, more than 6000 women with HIV become pregnant each year. Numerous interventions have been put into place which can decrease the risk of newborn HIV infection to less than one percent for many patients. The Women and Infants Transmission Study (WITS)... Read More

Effective Microbicide to Prevent HIV Transmission

Sep 09, 2010

The CAPRISA 004 trial in South Africa found that the use of tenofovir gel, a microbicide, by women prior to and after sex led to a decrease in HIV transmission. Women were followed for 30 months. Those with a high adherence rate to gel usage showed a 54% reduction in HIV... Read More

Opt-Out HIV Testing in EDs - Effective?

Sep 08, 2010

Diagnostic HIV testing was compared to nontargeted opt-out rapid HIV testing in an emergency department. Approximately 75% of ED patients declined HIV testing when offered. Of those identified to have a new HIV diagnosis, slightly more were identified through opt-out... Read More

Pre-exposure Prophylaxis Among Serodiscordant Couples

Sep 08, 2010

This commentary proposes the use of periconception pre-exposure prophylaxis (PrEP) in preventing HIV transmission between serodiscordant couples interested in conceiving. While methods such as artificial insemination and sperm washing are alternatives, these are not... Read More

Lopinavir/Ritonavir and Dosing During Pregnancy

Aug 23, 2010

Although recommended as the preferred protease inhibitor for antiretroviral therapy during pregnancy, optimal dosing for Lopinavir/Ritonavir has not been provided in the guidelines. This study looked at providing an increased dose (3 tablets daily versus two) during the... Read More

How Often Does HIV Vaccine Trial Participation Produce False-Positive Results?

Aug 18, 2010

The continuation of HIV vaccine trials have raised the question of the frequency of vaccine-induced seropositivity (VISP) as a result of participation in the trials. This study found that 42% of study participants had VISP but were truly HIV-seronegative. The rates of... Read More

Pages